Long Island man critically injured after entering MRI room without permission and being sucked into machine, cops say
The incident occurred at Nassau Open MRI around 4:30pm Wednesday, according to Nassau County police. The magnetic pull of the MRI machine dragged the man into the machine by way of his metal chain.
The man was not supposed to be in the room, and it is unclear based on initial reports why he entered.
Police said the man suffered a "medical episode" and was taken to a local hospital for treatment. He was last described as being in critical condition, PIX11 reports.
MRI machines are designed to find ailments in the body using powerful magnets. The magnets create a strong magnetic field which is used in scanning bodies.
The machines can then produce an image of a person's soft tissue that allow doctors to look for abnormalities, like tumors, or damage to internal organs, according to the National Institute of Biomedical Imaging and Bioengineering.
A 61-year-old man in New York was injured when he entered a room with an active MRI machine while wearing a metal chain around his neck. (stock image) (AFP/Getty)
'The magnetic field extends beyond the machine and exerts very powerful forces on objects of iron, some steels, and other magnetizable objects; it is strong enough to fling a wheelchair across the room,' the institute explains.
This is why MRI technicians are thorough when making sure that patients have no metal on their person — or inside their bodies — before they are imaged using an MRI machine.
"The static magnetic field of the MRI system is exceptionally strong. A 1.5 T magnet generates a magnetic that is approximately 21,000 greater than the earth's natural field," according to the University of California, San Francisco's Department of Radiology and Biomedical Imaging.
The department noted in a write-up about the potential hazards of MRI machines that magnetic metal objects "can become airborne projectiles". Even small objects — like paper clips or hairpins — can reach a terminal velocity of 40mph when pulled by an MRI's magnets.
In addition to the potential dangers from flying metal, MRI machine magnets can also erase credit cards, destroy phones, and shut down pacemakers.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
an hour ago
- New York Post
Mom paralyzed after Botox-like injections ‘poisoned' her body: ‘Worst decision I've ever made'
A mom who was left with partial paralysis thought she was 'slowly dying' after Botox-like injections 'poisoned' her body – and says she 'learned the cost of beauty the hard way.' Amanda Wolaver, 33, had been getting routine anti-wrinkle injections for 10 years with 'no issues' until a top-up left her with 'severe' headaches. She went to the hospital the next day after waking up 'unable to move,' but a CT scan revealed 'nothing was wrong.' 9 Amanda Wolaver (right), 33, had been getting routine anti-wrinkle injections for 10 years with 'no issues' until a touch-up left her with 'severe' headaches. Amanda Wolaver / SWNS Over 16 months, her symptoms worsened – she became housebound for four months and everyday tasks like showering and doing her make-up became a struggle – and an MRI revealed that she even suffered from TIA strokes. After $30,000 in tests later, a neurologist finally diagnosed Amanda with iatrogenic botulism. The rare neuromuscular disease is caused by botulinum neurotoxins – the active ingredient in Botox. Although there is no specific treatment, Amanda is 'recovering slowly' and letting time detoxify her body. Amanda, a sales director from Goodhope, Georgia, said: 'It's almost been two years and I still don't feel normal. 9 Wolaver went to the hospital the next day after waking up 'unable to move,' but a CT scan revealed 'nothing was wrong.' Amanda Wolaver / SWNS 'Never did I think this might happen to me. 'It was the worst decision I've ever made. 'I couldn't be the mother I wanted for my three children, Landen, 16, Braxton, 11, and Havyn, 5. 'As I was essentially a vegetable, unable to move, walk, drive, or do anything I love. 'But I'm grateful for the support of my husband, Josh, 39, who was there for me. 9 Over 16 months, her symptoms worsened – she became housebound for four months and everyday tasks like showering and doing her make-up became a struggle. Amanda Wolaver / SWNS 'I want my experience to educate others about botulinum toxins. 'I learned the cost of beauty the hard way.' Amanda paid $700 to have 104 units of Dysport – a Botox alternative she had never used before – injected into her forehead, crow's feet, and eleven lines in August 2023. 'I began developing this horrible migraine and thought if I slept it off, it would go away,' she said. 'However, when I woke up the next day, I couldn't function or string sentences together.' 9 An MRI revealed that Wolaver even suffered from TIA strokes. Amanda Wolaver / SWNS Botox and Dysport are neurotoxins that block muscle contractions to rid wrinkles, and both derive from botulinum toxin. Amanda visited the hospital and was told it was 'nothing to do with the injections.' 'They told me that it was probably just a severe migraine,' she said. 'But soon, my body felt like the floor was being ripped out from underneath me and that I'd collapse. 'My dizziness became so severe that I had to take Xanax to knock me out to sleep. 'I thought I was slowly dying.' 9 After numerous of testing, a neurologist finally diagnosed Amanda with iatrogenic botulism. Amanda Wolaver / SWNS Amanda visited doctors multiple times to find a cause and underwent a heart monitor implant and spinal tap surgeries. 'They thought I had MS at one point and an autoimmune disorder,' she added. 'I underwent around 10 to 15 different MRIs, CTs and multiple procedures. 'I felt like a lab rat.' Four months after her injections, a head and neck MR also revealed that the mom suffered from multiple TIA strokes. 9 Amanda, a sales director, said, 'It's almost been two years and I still don't feel normal.' Amanda Wolaver / SWNS 'That knocked me back,' she said. 'To be told I had suffered from multiple small strokes in my brain made me think that this would eventually kill me.' Her joint pain left her struggling to formulate sentences. 'My life was essentially ruined,' Amanda said. 9 'To be told I had suffered from multiple small strokes in my brain made me think that this would eventually kill me,' she continued. Amanda Wolaver / SWNS 'I lost friends and couldn't hang out with my family, as loud noises and strong smells would trigger my dizziness. 'So I couldn't even cook my kids' dinner or clean the house.' But it wasn't until she discovered a forum of people who had suffered Botox poisoning that it 'all came together.' In March 2025, she was diagnosed with iatrogenic botulism after doctors pinned the timing and correlation of her symptoms to her Dysport injections. 9 'I've cut out caffeine, soda, and even had my breast implants taken out in April to allow my body to detoxify itself,' she continued. Amanda Wolaver / SWNS 'It was a bittersweet moment,' she said. 'But there is no cure and no promise that I will be 100 per cent back to normal.' Six months later, Amanda still suffers daily with lasting effects. She said: 'I still get the occasional dizziness and I have changed my diet completely to make sure nothing bad is going in me. 9 'But now I want to create more awareness about the dangers of botulinum neurotoxins,' Wolaver said. Amanda Wolaver / SWNS 'I've cut out caffeine, soda, and even had my breast implants taken out in April to allow my body to detoxify itself. 'I don't care about my wrinkles at all now, and I'm getting more active and able to do more things with my family. 'But now I want to create more awareness about the dangers of botulinum neurotoxins. 'Hopefully, I can help prevent this from happening to others.'
Yahoo
3 hours ago
- Yahoo
SIGA to Host Business Update Call on August 5, 2025 Following Release of Second-Quarter 2025 Results
NEW YORK, July 29, 2025 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (Nasdaq: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Tuesday, August 5, 2025. Participating in the call will be Diem Nguyen, Chief Executive Officer, and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at in the Investor Relations section of the site, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-717-1738 for domestic callers or 1-646-307-1865 for international callers. A replay of the call will be available for two weeks by dialing 1-844-512-2921 for domestic callers or 1-412-317-6671 for international callers and using Conference ID: 1130215. The archived webcast will be available in the Investor Relations section of the Company's website. About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary focus on orthopoxviruses, we are dedicated to protecting humanity against the world's most severe infectious diseases, including those that occur naturally, accidentally, or intentionally. Through partnerships with governments and public health agencies, we work to build a healthier and safer world by providing essential countermeasures against these global health threats. Our flagship product, TPOXX® (tecovirimat), is an antiviral medicine approved in the U.S. and Canada for the treatment of smallpox and authorized in Europe, the UK, and Japan for the treatment of smallpox, mpox (monkeypox), cowpox, and vaccinia complications. For more information about SIGA, visit Contacts:Suzanne Harnettsharnett@ and Investors Media Jennifer Drew-Bear, Edison GroupJdrew-bear@ Holly Stevens, CG Lifehstevens@
Yahoo
3 hours ago
- Yahoo
Sarepta shares rebound after shipments of gene therapy Elevidys resume in US
(Reuters) -Sarepta Therapeutics shares surged more than 30% before the bell on Tuesday, as analysts said the resumption of U.S. shipments for its muscular gene therapy partially removes financial headwinds and decreases the risk of market withdrawal. The company said on Monday it would resume shipments of Elevidys — approved in the U.S. to treat a rare condition called Duchenne muscular dystrophy — to patients who can walk. U.S. shipments to patients who cannot walk independently are still halted, following the death of two teenage boys earlier this year. These incidents brought heightened regulatory scrutiny to Sarepta in recent weeks, while the pause of shipments raised concerns about the future of Elevidys — the company's largest revenue generator. Sarepta's announcement followed the U.S. Food and Drug Administration's recommendation that the voluntary hold on shipments be removed after a probe showed the death of an 8-year-old boy in Brazil was not related to Elevidys. Wall Street analysts said the resumption of shipments would allow Sarepta to fulfill its near-term payments to partner Arrowhead and maintain access to its debt facilities. "The FDA's recommendation and the resumption of commercial treatment in the U.S. virtually eliminate the risk of Elevidys being formally withdrawn from the market," said William Blair analyst Sami Corwin. While the decision allows some patients to regain access to the treatment, analysts warned that patients and doctors could show hesitancy in light of the recent hit to reputation. "It remains to be seen how the news headlines regarding the patient deaths will affect commercial interest in the near term," Corwin said. Sarepta's partner Roche had also stopped Elevidys shipments in certain countries outside the U.S. Shares of Sarepta surged 36% to $18.85 in premarket trading. They have fallen more than 80% since the first Elevidys-related death was reported in March. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
